Version 1
: Received: 31 July 2020 / Approved: 2 August 2020 / Online: 2 August 2020 (12:07:34 CEST)
Version 2
: Received: 10 February 2021 / Approved: 10 February 2021 / Online: 10 February 2021 (15:04:19 CET)
How to cite:
Jolly, M. K.; Murphy, R. J.; Bhatia, S.; Whitfield, H. J.; Redfern, A.; Davis, M. J.; Thompson, E. W. Measuring and Modelling the Epithelial Mesenchymal Hybrid State in Cancer: Clinical Implications. Preprints2020, 2020080023
Jolly, M. K.; Murphy, R. J.; Bhatia, S.; Whitfield, H. J.; Redfern, A.; Davis, M. J.; Thompson, E. W. Measuring and Modelling the Epithelial Mesenchymal Hybrid State in Cancer: Clinical Implications. Preprints 2020, 2020080023
Jolly, M. K.; Murphy, R. J.; Bhatia, S.; Whitfield, H. J.; Redfern, A.; Davis, M. J.; Thompson, E. W. Measuring and Modelling the Epithelial Mesenchymal Hybrid State in Cancer: Clinical Implications. Preprints2020, 2020080023
APA Style
Jolly, M. K., Murphy, R. J., Bhatia, S., Whitfield, H. J., Redfern, A., Davis, M. J., & Thompson, E. W. (2021). Measuring and Modelling the Epithelial Mesenchymal Hybrid State in Cancer: Clinical Implications. Preprints. https://doi.org/
Chicago/Turabian Style
Jolly, M. K., Melissa J. Davis and Erik W. Thompson. 2021 "Measuring and Modelling the Epithelial Mesenchymal Hybrid State in Cancer: Clinical Implications" Preprints. https://doi.org/
Abstract
The epithelial-mesenchymal (E/M) hybrid state has emerged as an important mediator of elements of cancer progression, facilitated by epithelial mesenchymal plasticity (EMP). We review here evidence for the presence, prognostic significance, and therapeutic potential of the E/M hybrid state in carcinoma. We further assess modelling predictions and validation studies to demonstrate stabilised E/M hybrid states along the spectrum of EMP, as well as computational approaches for characterising and quantifying EMP phenotypes, with particular attention to the emerging realm of single-cell approaches through RNA sequencing and protein-based techniques.
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Commenter: Mohit Kumar Jolly
Commenter's Conflict of Interests: Author